Leslie Johnston Browne (pronounced Brown; 3 February 1950, Glasgow, Scotland) is a chemist and entrepreneur. Browne made important drug discoveries throughout the late 20th and early 21st century in the pharmaceutical industry. His most well known commercialized contributions include drugs for the treatment of various forms of cancer and cardiovascular disease. In addition to the discovery of , the first marketed non-steroidal aromatase inhibitor for the treatment of estrogen-dependent breast cancer, he led the team that discovered , the second angiotensin II antagonist ever to be marketed. He has been a pharmaceutical industry leader and visionary for the last decade making public speaking appearances at both business and technical conferences across the globe.
Browne is widely considered to be one of the drug discovery's most versatile leaders of the early 21st century combining world leading acumen in hands on drug discovery with some of the managerial acumen of a seasoned entrepreneur. He is also a prolific writer having authored numerous publications and patents covering a broad range of therapeutic areas including CNS, cardiovascular disease, inflammation and cancer. He currently has 17 patents to his name.
Dr. Browne has over twenty years of experience in the pharmaceutical industry and has devoted the most distinguished years of his career to entrepreneurship in the pharmaceutical space. He was the President and CEO of . Dr. Browne was the Chief Operating... Read More